Revenue
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Talphera, Inc. (TLPH)
Price$1.20Cached quote
Net income
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total cash / debt
CashTotal debt
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $28,000 | $0 | $651,000 | $0 | $2.8M | $5.4M | $2.3M | $2.2M | $8.0M | $17.4M | $19.3M | $5.2M | $29.5M | $2.4M | $1.1M | — | — | — | — | — |
| Gross profit | — | — | — | −$2.6M | −$935,000 | −$616,000 | −$4.5M | −$1.8M | −$2.7M | $5.0M | $17.5M | — | — | — | — | — | — | — | — | — |
| Gross margin | — | — | — | — | −33.18% | −11.37% | −197.34% | −84.84% | −33.32% | 29.05% | 90.81% | — | — | — | — | — | — | — | — | — |
| Research & development | $6.0M | $6.7M | $5.5M | $3.3M | $4.1M | $4.0M | $4.7M | $13.1M | $19.4M | $21.4M | $22.5M | $24.5M | $26.3M | $24.9M | $13.6M | $8.2M | $15.5M | — | — | — |
| Operating expenses | $13.5M | $15.3M | $17.5M | $25.3M | $38.8M | $46.4M | $56.5M | $37.9M | $46.7M | $49.3M | $39.2M | $42.9M | $36.2M | $32.1M | $20.4M | $12.2M | $19.0M | — | — | — |
| Operating income | −$13.5M | −$15.3M | −$16.9M | −$25.3M | −$36.0M | −$41.0M | −$54.2M | −$35.7M | −$38.7M | −$32.0M | −$20.0M | −$37.6M | −$6.7M | — | — | — | — | — | — | — |
| Operating margin | −48,157.14% | — | −2,594.32% | — | −1,276.26% | −756.33% | −2,368.06% | −1,660.95% | −483.83% | −184.12% | −103.59% | −721.66% | −22.60% | — | — | — | — | — | — | — |
| EBITDA | −$14.4M | −$15.3M | −$16.6M | −$23.7M | −$34.0M | −$39.1M | −$52.5M | −$35.2M | −$36.9M | −$29.9M | −$18.0M | −$36.8M | −$6.1M | — | — | — | — | — | — | — |
| EBITDA margin | −51,296.43% | — | −2,546.54% | — | −1,206.25% | −722.12% | −2,295.19% | −1,634.22% | −462.01% | −172.29% | −93.29% | −705.06% | −20.59% | — | — | — | — | — | — | — |
| Net income | −$14.3M | −$13.0M | −$18.4M | $47.8M | −$35.1M | −$40.4M | −$53.2M | −$47.1M | −$51.5M | −$43.2M | −$24.4M | −$33.4M | −$23.4M | −$33.4M | −$20.1M | −$14.3M | −$20.1M | −$20.7M | −$9.6M | −$3.8M |
| Net profit margin | −51,035.71% | — | −2,825.96% | — | −1,245.53% | −745.55% | −2,325.91% | −2,191.96% | −644.25% | −248.64% | −126.66% | −639.31% | −79.40% | −1,393.61% | −1,875.09% | — | — | — | — | — |
| Basic EPSper basic share | -$0.34 | -$0.50 | -$1.29 | $5.73 | -$5.86 | -$9.40 | -$13.40 | -$16.20 | -$22.00 | -$19.00 | -$11.00 | -$15.40 | -$11.80 | -$30.20 | -$23.20 | -$436.80 | -$698.60 | — | — | — |
| Diluted EPSper diluted share | -$0.34 | -$0.50 | -$1.29 | $5.72 | -$5.86 | -$9.40 | -$13.40 | -$16.20 | -$22.00 | -$19.00 | -$12.00 | -$18.20 | -$11.80 | -$30.20 | -$23.20 | -$436.80 | -$698.60 | — | — | — |
Owners
Reported shareholders
≈17.51%of listed shares
CorMedix Inc.9.09M shares · Sep 7, 2025
View holders
| Holder | % owned |
|---|---|
CorMedix Inc. | ≈17.51%9.09M shares |
Nantahala Capital Management, LLC | 13.46%6.99M shares |
Rosalind Advisors, Inc. | 9.96%5.17M shares |
AIGH Capital Management LLC | 8.87%4.6M shares |
Rock Springs Capital Management LP | 6.91%3.59M shares |
CANTOR FITZGERALD, L. P. | 3.42%1.77M shares |
Bleichroeder LP | 2.52%1.31M shares |
Angotti Vincent J. | ≈1.52%790.77K shares |
Dauntless Investment Group, LLC | 1.44%746.05K shares |
VANGUARD CAPITAL MANAGEMENT LLC | 1.35%701.88K shares |
Caption Management, LLC | 0.99%514.97K shares |
Almitas Capital LLC | 0.90%467.15K shares |
GEODE CAPITAL MANAGEMENT, LLC | 0.83%429.06K shares |
Shay Capital LLC | 0.78%405.76K shares |
VANGUARD FIDUCIARY TRUST CO | 0.43%222.37K shares |
GSA CAPITAL PARTNERS LLP | 0.40%209.36K shares |
DIADEMA PARTNERS LP | 0.30%153.56K shares |
UBS Group AG | 0.25%129.92K shares |
RENAISSANCE TECHNOLOGIES LLC | 0.22%113.3K shares |
Mariner, LLC | 0.19%100K shares |
Percentages use 51.91M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 3 ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Mar 13, 2026Form 4 | Angotti Vincent J.CHIEF EXECUTIVE OFFICER | BuyCommon Stock | 213.3K | $0.59 | $125.9K | 800.7K |
| Feb 12, 2026Form 4 | Aslam ShakilChief Medical Officer | BuyCommon Stock | 35.0K | $0.81 | $28.4K | 83.2K |
| Feb 12, 2026Form 4 | Angotti Vincent J.CHIEF EXECUTIVE OFFICER | BuyCommon Stock | 105.4K | $0.81 | $85.3K | 587.0K |
| Feb 12, 2026Form 4 | ASADORIAN RAFFIChief Financial Officer | BuyCommom Stock | 45.0K | $0.81 | $36.5K | 91.3K |
| Feb 12, 2026Form 4 | Dasu Badri NChief Engineering Officer | BuyCommon Stock | 35.0K | $0.81 | $28.4K | 76.2K |